ABWIX
Price
$15.59
Change
+$0.07 (+0.45%)
Updated
Jan 17 closing price
Net Assets
421.28M
RIRBX
Price
$70.01
Change
+$0.35 (+0.50%)
Updated
Jan 17 closing price
Net Assets
106.93B
Ad is loading...

ABWIX vs RIRBX

Header iconABWIX vs RIRBX Comparison
Open Charts ABWIX vs RIRBXBanner chart's image
AB All Market Total Return I
Price$15.59
Change+$0.07 (+0.45%)
VolumeN/A
Net Assets421.28M
American Funds Capital Income Bldr R2
Price$70.01
Change+$0.35 (+0.50%)
VolumeN/A
Net Assets106.93B
ABWIX vs RIRBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ABWIX vs. RIRBX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABWIX is a Buy and RIRBX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RIRBX has more cash in the bank: 107B vs. ABWIX (421M). RIRBX pays higher dividends than ABWIX: RIRBX (2.55) vs ABWIX (1.40). ABWIX was incepted earlier than RIRBX: ABWIX (20 years) vs RIRBX (23 years). RIRBX is a more actively managed with annual turnover of: 106.00 vs. ABWIX (70.00). ABWIX has a lower initial minimum investment than RIRBX: ABWIX (0) vs RIRBX (250). ABWIX annual gain was more profitable for investors over the last year : 11.37 vs. RIRBX (9.89). RIRBX return over 5 years is better than : 19.51 vs. ABWIX (5.36).
ABWIXRIRBXABWIX / RIRBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years23 years-
Gain YTD1.0371.40574%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets421M107B0%
Annual Yield % from dividends1.402.5555%
Returns for 1 year11.379.89115%
Returns for 3 years2.995.6553%
Returns for 5 years5.3619.5127%
Returns for 10 years33.9730.09113%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PTCT43.840.76
+1.76%
PTC Therapeutics
CBAN15.840.22
+1.41%
Colony Bankcorp Inc
ABCL2.970.03
+1.02%
AbCellera Biologics
PAVM0.650.01
+0.81%
PAVmed
EXPE187.28-1.39
-0.74%
Expedia Group